Alimera Sciences, Inc. revenue breakdown overview

Alimera Sciences, Inc. revenue for the last year amounted to 80.75 M USD, the most of which — 80.75 M USD — came from its highest performing source at the moment, Ophthalmic Retinal Pharmaceuticals, the year earlier bringing 54.13 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Alimera Sciences, Inc. 56.71 M USD, and the year before that — 34.20 M USD.